BCAB - BioAtla, Inc.
0.4298
-0.043 -10.051%
Share volume: 378,528
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.47
-0.04
-0.09%
Summary score
34%
Profitability
35%
Dept financing
35%
Liquidity
49%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-21.59%
Return on sales
-102.45%
Return on invested capital
0%
Total debt ratio
42.36%
Debt ratio change over timeo
0%
Current Ratio
5.9%
Quick Ratio
0%
Cash Position Ratio
5.67%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-30.17%
Return on sales
-102.45%
Return on invested capital
0%
Total debt ratio
72.19%
Debt ratio change over timeo
0%
Current Ratio
3.2%
Quick Ratio
0%
Cash Position Ratio
2.96%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-41.09%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
98.57%
Debt ratio change over time
0%
Current Ratio
2.35%
Quick Ratio
0%
Cash Position Ratio
2.02%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BCAB | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 18.97% | 6.3% | 14.13% |
| Return on assets | -21.59% | 3.05% | 3.04% | 13.28% |
| Return on sales | -102.45% | 29.08% | 27.81% | 1.7% |
| Return on invested capital | 0% | 5.17% | 3.5% | -46.9% |
| Profitability | 0% | 81% | 55% | 45% |
| Total debt ratio | 42.36% | 92.73% | 66.91% | 19.17% |
| Debt ratio change over time | 0% | 21.88% | 144.36% | -1.07% |
| Dept financing | 11% | 29% | 43% | 5% |
| Current Ratio | 3.2% | 1.25% | 1.34% | 0% |
| Quick Ratio | 0% | 0.92% | 1.18% | 0% |
| Cash Position Ratio | 2.96% | 0.44% | 0.54% | 0% |
| Liquididy | 45% | 14% | 11% | 68% |
| Short-term ratios | BCAB | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -30.17% | 2.68% | 3.48% | 0% |
| Return on sales | -102.45% | 21.68% | 28.93% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 38% | 50% | 0% |
| Total debt ratio | 72.19% | 92.96% | 66.32% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 44% | 25% | 18% | 0% |
| Current Ratio | 3.2% | 1.25% | 1.34% | 0% |
| Quick Ratio | 0% | 0.92% | 1.18% | 0% |
| Cash Position Ratio | 2.96% | 0.44% | 0.54% | 0% |
| Liquididy | 50% | 33% | 40% | 0% |
